Related Experiment Video
Updated: Aug 20, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Neonatal and early-onset diabetes in Ukraine: Atypical features and mortality
Evgenia Globa1, Nataliya Zelinska1, Matthew B Johnson2
1Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine.
Insights
Genetic testing identified the causes of most neonatal diabetes cases in Ukraine. Rare genetic subtypes were linked to a high mortality rate in infants diagnosed before six months of age.
Area of Science:
- Pediatric Endocrinology
- Medical Genetics
- Neonatology
Background:
- Neonatal and early-onset diabetes are rare conditions with diverse genetic causes.
- Accurate diagnosis is crucial for appropriate management and understanding prognosis.
- Genetic testing has become increasingly important in identifying specific subtypes of pediatric diabetes.
Purpose of the Study:
- To investigate the genetic aetiology and clinical characteristics of neonatal and early-onset diabetes in Ukrainian children.
- To identify the prevalence of different genetic subtypes in this cohort.
- To assess the mortality rate associated with these conditions.
Main Methods:
- Established a Pediatric Diabetes Register for patients diagnosed before 9 months of age.
- Conducted genetic testing on 66 patients from 65 families with diabetes diagnosed within the first 9 months of life.
- Classified patients into neonatal diabetes (diagnosed before 6 months) and early-onset diabetes (diagnosed between 6-9 months).
Main Results:
- Determined genetic aetiology in 86.1% of neonatal diabetes and 20% of early-onset diabetes cases.
- Identified common variants in ABCC8, KCNJ11, INS, GCK, and 6q24 transient neonatal diabetes.
- Discovered rare genetic subtypes in 24.3% of solved cases, with a high mortality rate (6/9) among these.
- Observed that all eight childhood deaths occurred in patients diagnosed before 6 months with a genetic diagnosis.
Conclusions:
- Comprehensive genetic testing has improved the recognition of rare genetic diabetes subtypes in pediatric populations.
- A significant proportion of neonatal diabetes cases have identifiable genetic causes.
- Rare genetic subtypes of neonatal diabetes are associated with a high mortality rate, highlighting the need for early diagnosis and specialized care.
Aims:
The aim of this study is to elucidate the aetiology and clinical features of neonatal and early-onset diabetes in a large database for pediatric diabetes patients in Ukraine.
Methods:
We established a Pediatric Diabetes Register to identify patients diagnosed with diabetes before 9 months of age. Genetic testing was undertaken for 66 patients from 65 unrelated families with diabetes diagnosed within the first 6 months of life (neonatal diabetes, n = 36) or between 6 and 9 months (early-onset diabetes, n = 30).
Results:
We determined the genetic aetiology in 86.1% of patients (31/36) diagnosed before 6 months and in 20% (6/30) diagnosed between 6 and 9 months. Fourteen individuals (37.8% of those with a genetic cause identified) had activating heterozygous variants in ABCC8 or KCNJ11. An additional 10 individuals had pathogenic variants in the INS or GCK genes, while 4 had 6q24 transient neonatal diabetes. Rare genetic subtypes (including pathogenic variants in EIF2AK3, GLIS3, INSR, PDX1, LRBA, RFX6 and FOXP3) were identified in nine probands (24.3% of solved cases), 6 of whom died. In total, eight individuals died between infancy and childhood, all of them were diagnosed before 6 months and had received a genetic diagnosis.
Conclusions:
In the last decade, the increased availability of comprehensive genetic testing has resulted in increased recognition of the contribution of rare genetic subtypes within pediatric diabetes cohorts. In our study, we identified a high mortality rate among these patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Inborn Errors of Metabolism

